TY - JOUR
T1 - Understanding pneumococcal serotype 1 biology through population genomic analysis
AU - for the PAGe Consortium
AU - Chaguza, Chrispin
AU - Cornick, Jennifer E.
AU - Harris, Simon R.
AU - Andam, Cheryl P.
AU - Bricio-Moreno, Laura
AU - Yang, Marie
AU - Yalcin, Feyruz
AU - Ousmane, Sani
AU - Govindpersad, Shanil
AU - Senghore, Madikay
AU - Ebruke, Chinelo
AU - Du Plessis, Mignon
AU - Kiran, Anmol M.
AU - Pluschke, Gerd
AU - Sigauque, Betuel
AU - McGee, Lesley
AU - Klugman, Keith P.
AU - Turner, Paul
AU - Corander, Jukka
AU - Parkhill, Julian
AU - Collard, Jean Marc
AU - Antonio, Martin
AU - von Gottberg, Anne
AU - Heyderman, Robert S.
AU - French, Neil
AU - Kadioglu, Aras
AU - Hanage, William P.
AU - Everett, Dean B.
AU - Bentley, Stephen D.
N1 - Funding Information:
We would like to thank all the clinical and laboratory staff at all the collaborating institutions, the sequencing teams at the Wellcome Trust Sanger Institute for their expertise. We are also grateful to the Global Pneumococcal Strain Bank (a PATH-funded collaboration between the US Centre for Disease Control and Prevention (CDC), Emory University, and others) for providing additional isolates for the study., This work was supported by funds from the Bill and Melinda Gates Foundation (BMGF) (grant number: OPP1023440 awarded to DBE [http:// www.pagegenomes.org/page/consortium]) and The Wellcome Trust Major Overseas programme core award (Award number: 084679/Z/08/Z). CC acknowledges support in form of a PhD scholarship from the Commonwealth Scholarship Commission, UK. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript.
Funding Information:
This work was supported by funds from the Bill and Melinda Gates Foundation (BMGF) (grant number: OPP1023440 awarded to DBE [http:// www.pagegenomes.org/page/consortium]) and The Wellcome Trust Major Overseas programme core award (Award number: 084679/Z/08/Z). CC acknowledges support in form of a PhD scholarship from the Commonwealth Scholarship Commission, UK.
Publisher Copyright:
© 2016 The Author(s).
PY - 2016/11/8
Y1 - 2016/11/8
N2 - Background: Pneumococcus kills over one million children annually and over 90 % of these deaths occur in low-income countries especially in Sub-Saharan Africa (SSA) where HIV exacerbates the disease burden. In SSA, serotype 1 pneumococci particularly the endemic ST217 clone, causes majority of the pneumococcal disease burden. To understand the evolution of the virulent ST217 clone, we analysed ST217 whole genomes from isolates sampled from African and Asian countries. Methods: We analysed 226 whole genome sequences from the ST217 lineage sampled from 9 African and 4 Asian countries. We constructed a whole genome alignment and used it for phylogenetic and coalescent analyses. We also screened the genomes to determine presence of antibiotic resistance conferring genes. Results: Population structure analysis grouped the ST217 isolates into five sequence clusters (SCs), which were highly associated with different geographical regions and showed limited intracontinental and intercontinental spread. The SCs showed lower than expected genomic sequence, which suggested strong purifying selection and small population sizes caused by bottlenecks. Recombination rates varied between the SCs but were lower than in other successful clones such as PMEN1. African isolates showed higher prevalence of antibiotic resistance genes than Asian isolates. Interestingly, certain West African isolates harbored a defective chloramphenicol and tetracycline resistance-conferring element (Tn5253) with a deletion in the loci encoding the chloramphenicol resistance gene (cat pC194), which caused lower chloramphenicol than tetracycline resistance. Furthermore, certain genes that promote colonisation were absent in the isolates, which may contribute to serotype 1's rarity in carriage and consequently its lower recombination rates. Conclusions: The high phylogeographic diversity of the ST217 clone shows that this clone has been in circulation globally for a long time, which allowed its diversification and adaptation in different geographical regions. Such geographic adaptation reflects local variations in selection pressures in different locales. Further studies will be required to fully understand the biological mechanisms which makes the ST217 clone highly invasive but unable to successfully colonise the human nasopharynx for long durations which results in lower recombination rates.
AB - Background: Pneumococcus kills over one million children annually and over 90 % of these deaths occur in low-income countries especially in Sub-Saharan Africa (SSA) where HIV exacerbates the disease burden. In SSA, serotype 1 pneumococci particularly the endemic ST217 clone, causes majority of the pneumococcal disease burden. To understand the evolution of the virulent ST217 clone, we analysed ST217 whole genomes from isolates sampled from African and Asian countries. Methods: We analysed 226 whole genome sequences from the ST217 lineage sampled from 9 African and 4 Asian countries. We constructed a whole genome alignment and used it for phylogenetic and coalescent analyses. We also screened the genomes to determine presence of antibiotic resistance conferring genes. Results: Population structure analysis grouped the ST217 isolates into five sequence clusters (SCs), which were highly associated with different geographical regions and showed limited intracontinental and intercontinental spread. The SCs showed lower than expected genomic sequence, which suggested strong purifying selection and small population sizes caused by bottlenecks. Recombination rates varied between the SCs but were lower than in other successful clones such as PMEN1. African isolates showed higher prevalence of antibiotic resistance genes than Asian isolates. Interestingly, certain West African isolates harbored a defective chloramphenicol and tetracycline resistance-conferring element (Tn5253) with a deletion in the loci encoding the chloramphenicol resistance gene (cat pC194), which caused lower chloramphenicol than tetracycline resistance. Furthermore, certain genes that promote colonisation were absent in the isolates, which may contribute to serotype 1's rarity in carriage and consequently its lower recombination rates. Conclusions: The high phylogeographic diversity of the ST217 clone shows that this clone has been in circulation globally for a long time, which allowed its diversification and adaptation in different geographical regions. Such geographic adaptation reflects local variations in selection pressures in different locales. Further studies will be required to fully understand the biological mechanisms which makes the ST217 clone highly invasive but unable to successfully colonise the human nasopharynx for long durations which results in lower recombination rates.
KW - Antibiotic resistance
KW - Evolution
KW - Phylogeography
KW - Pneumococcal serotype 1
KW - ST217
UR - https://www.scopus.com/pages/publications/84994440964
U2 - 10.1186/s12879-016-1987-z
DO - 10.1186/s12879-016-1987-z
M3 - Article
C2 - 27821148
AN - SCOPUS:84994440964
SN - 1471-2334
VL - 16
JO - BMC Infectious Diseases
JF - BMC Infectious Diseases
IS - 1
M1 - 649
ER -